Wang, Chih-Ya <br/><br/>
A novel action mechanism for MPT0G013, a derivative of arylsulfonamide, inhibits tumor angiogenesis through up-regulation of TIMP3 expression.  [electronic resource] 

 -  Oncotarget  Oct 2014 
 - 9838-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.2451  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacology<br/>Animals<br/>Apoptosis--drug effects<br/>Cell Cycle Checkpoints<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Colonic Neoplasms--blood supply<br/>Female<br/>G1 Phase Cell Cycle Checkpoints--drug effects<br/>HCT116 Cells<br/>Human Umbilical Vein Endothelial Cells--drug effects<br/>Humans<br/>Hydroxamic Acids--pharmacology<br/>Indoles--pharmacology<br/>Male<br/>Mice<br/>Mice, Nude<br/>Mice, SCID<br/>Neovascularization, Pathologic--drug therapy<br/>Signal Transduction<br/>Tissue Inhibitor of Metalloproteinase-3--antagonists & inhibitors<br/>Up-Regulation--drug effects<br/>Xenograft Model Antitumor Assays